(Hypertension. 1995;26:1134-1137.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Internal Medicine, Hypertension and Vascular Research Laboratories, University of Texas Medical Branch, Galveston.
Correspondence to Donna H. Wang, MD, The University of Texas Medical Branch, Department of Internal Medicine, Hypertension and Vascular Research Laboratories, 8.104 Medical Research Bldg, Galveston, TX 77555-1065. E-mail dwang%intmeds1@mhost.utmb.edu.
Abstract We previously demonstrated that type 1A angiotensin II (Ang II) receptor (AT1A) is the predominant renal subtype and is upregulated by a low sodium diet. We have now tested the hypothesis that upregulation of AT1A mRNA induced by sodium deficiency is renal specific and is mediated by activation of type 1 Ang II receptor (AT1). Male Wistar rats were divided into four groups (n=5 each) and treated for 2 weeks with normal sodium diet (0.5%), normal sodium plus 3 mg/kg per day losartan, low sodium diet (0.07%), or low sodium diet plus losartan. At the end of the 2 weeks, body weight and mean arterial pressure were not different among the four groups (P>.05). Plasma renin activity was elevated by losartan treatment, sodium restriction, or the combination of the two versus control (P<.05). Northern blot analysis showed that the ratio of renal AT1A to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA was increased by losartan treatment, sodium restriction, or the combination of the two versus control (P<.05). In contrast, the ratio of adrenal AT1A to GAPDH mRNA was increased only by sodium restriction versus three other groups (P<.05). Thus, sodium deficiency increases AT1A mRNA in both kidney and adrenal gland, while Ang II receptor blockade by losartan prevents low sodiuminduced AT1A mRNA only in adrenal gland. We conclude that the increase in AT1A mRNA induced by sodium deficiency is not renal specific and that different mechanisms of regulation exist, ie, in adrenal gland, low sodiuminduced upregulation of AT1A is dependent upon Ang II activation of the AT1 receptor, while in kidney, a non-AT1dependent mechanism is operant.
Key Words: receptor, angiotensin II genes sodium kidney adrenal gland
This article has been cited by other articles:
![]() |
J. M. Perez-Rojas, S. Derive, J. A. Blanco, C. Cruz, L. M. de la Maza, G. Gamba, and N. A. Bobadilla Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1020 - F1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Imig, G. L. Navar, L.-X. Zou, K. C. O'Reilly, P. L. Allen, J. H. Kaysen, T. G. Hammond, and L. G. Navar Renal endosomes contain angiotensin peptides, converting enzyme, and AT1A receptors Am J Physiol Renal Physiol, August 1, 1999; 277(2): F303 - F311. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Wang, A. Yao, H. Zhao, and D. J. DiPette Distinct Mechanisms of Modulation of Angiotensin II Type I Receptor Gene Expression in Heart and Aorta Hypertension, May 1, 1997; 29(5): 1104 - 1108. [Abstract] [Full Text] |
||||
![]() |
F. Elijovich, H.-W. Zhao, C. L. Laffer, Y. Du, D. J. DiPette, T. Inagami, and D. H. Wang Regulation of Growth of the Adrenal Gland in DOC-Salt Hypertension: Role of Angiotensin II Receptor Subtypes Hypertension, January 1, 1997; 29(1): 408 - 413. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |